1Hance KW,Anderson WF,Devesa SS,et al.Trends in inflammatory breast carcinoma incidence and survival:the Surveillance,Epidemiology and End Results program at National Cancer Institute.J Natl Cancer Inst,2005,97:966-975.
2Yang WT,Le Petross HT,Macapinlac H,et al.Inflammatory breast cancer; PET/CT,MRI,mammography,and sonography findings.Breast Cancer Res Treat,2008,109:417-426.
3Anderson WF,Chu KC,Chang S,et al.Inflammatory breast carcinoma and noninflammatory locally advanced breast carcinomas:distinct clinicopathologic entities? J Clin Oncol,2003,21:2254-2259.
4Le MG,Arriagada R,Bahi J,et al.Are risk factors for breast cancer similar in women with inflammatory breast cancer and in those with non-inflammatory breast cancer? Breast,2006,15;355-362.
5Colpaert CG,Verrmeulen PB,Benoy I,et al.Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression.Br J Cancer,2003,88;718-725.
6Tomlinson JS,Alpaugh ML,Barsky SH,et al.An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma.Cancer Res,2001,61:5231-5241.
7Alpaugh ML,Tomlinson JS,Ye Y,et al.Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma.Am J Pathol,2002,161:619-628.
8Bieche I,Lerebours F,Tozlu S,et al.Molecular profiling of inflammatory breast cancer:identification of a poor-prognosis gene expression signature.Clin Cancer Res,2004,10:6789-6795.
9Van der Auwera I,Van Laere SJ,Van den Eynden GG,et al.Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.Clin Cancer Res,2004,10:7965-7971.
10He Y,Rajantie I,Pajusola K,et al.Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels.Cancer Res,2005,65:4739-4746.
9Hance KW, Anderson WF, Devesa SS, et al. Trends in inflammato- ry breast carcinoma incidence and survival:the Surveillance, Epi- demiology and End Results program at National Cancer Institute [ J ]. J Nat 1 Cancer Inst,2005,97 ( 13 ) :966 - 975.
10Fredika M. Roberston, Melissa Bondy, Wei Yang, et al. Inflammato- ry breast cancer: the disease, the biology, the treatment [ J ]. CA Cancer J Clin,2010,60(6) :351 -375.